AIA Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $861K | Buy |
6,852
+2,006
| +41% | +$252K | 0.02% | 237 |
|
|
2025
Q1 | $663K | Buy |
+4,846
| New | +$663K | 0.02% | 246 |
|
|
2024
Q4 | – | Sell |
-1,411
| Closed | -$274K | – | 299 |
|
|
2024
Q3 | $274K | Buy |
1,411
+135
| +11% | +$26.2K | 0.01% | 270 |
|
|
2024
Q2 | $296K | Sell |
1,276
-188
| -13% | -$43.6K | 0.01% | 263 |
|
|
2024
Q1 | $316K | Sell |
1,464
-99
| -6% | -$21.3K | 0.01% | 269 |
|
|
2023
Q4 | $404K | Sell |
1,563
-141
| -8% | -$36.5K | 0.02% | 244 |
|
|
2023
Q3 | $438K | Buy |
1,704
+80
| +5% | +$20.6K | 0.02% | 223 |
|
|
2023
Q2 | $463K | Sell |
1,624
-2,348
| -59% | -$669K | 0.02% | 254 |
|
|
2023
Q1 | $1.1M | Sell |
3,972
-200
| -5% | -$55.6K | 0.06% | 143 |
|
|
2022
Q4 | $1.16M | Buy |
4,172
+3,452
| +479% | +$956K | 0.07% | 120 |
|
|
2022
Q3 | $192K | Sell |
720
-5,580
| -89% | -$1.49M | 0.01% | 297 |
|
|
2022
Q2 | $1.29M | Buy |
6,300
+4,103
| +187% | +$837K | 0.07% | 123 |
|
|
2022
Q1 | $463K | Buy |
2,197
+652
| +42% | +$137K | 0.02% | 245 |
|
|
2021
Q4 | $371K | Sell |
1,545
-118
| -7% | -$28.3K | 0.02% | 207 |
|
|
2021
Q3 | $471K | Buy |
1,663
+614
| +59% | +$174K | 0.03% | 177 |
|
|
2021
Q2 | $340K | Buy |
+1,049
| New | +$340K | 0.02% | 167 |
|
|
2021
Q1 | – | Sell |
-2,040
| Closed | -$537K | – | 180 |
|
|
2020
Q4 | $537K | Buy |
+2,040
| New | +$537K | 0.06% | 114 |
|